|
CHM |
CFO certification of the 03-31-2024 quarterly filing |
Other |
15/05/2024 |
 Open Filing (139.84 KB) |
|
RWB |
Financial Statements Request Form |
Other |
15/05/2024 |
Open Filing (97.37 KB) |
|
CHM |
MD&A for the quarter ended March 31, 2024, as filed 05/15/2024 |
MD&A (Management Discussion and Analysis) |
15/05/2024 |
Open Filing (419 KB) |
|
RWB |
FORM OF PROXY |
Form of Proxy |
15/05/2024 |
Open Filing (132.52 KB) |
|
RWB |
RED WHITE & BLOOM BRANDS INC. NOTICE AND ACCESS NOTIFICATION TO SHAREHOLDERS ANNUAL GENERAL & SPECIAL MEETING OF SHAREHOLDERS |
Notice of Meeting |
15/05/2024 |
Open Filing (140.72 KB) |
|
CHM |
Quarterly financial statements for the period ended March 31, 2024 |
Interim Financial Statements |
15/05/2024 |
Open Filing (435.3 KB) |
|
RWB |
RED WHITE & BLOOM BRANDS INC. Notice and Information Circular |
Management Proxy/Information Circular |
15/05/2024 |
Open Filing (2.19 MB) |
|
CHM |
Form 5 - Quarterly Listing Statement quarter-ended 03-31-2024 |
Quarterly Listing Statement |
15/05/2024 |
Open Filing (858.37 KB) |
|
BIOV |
BioVaxys Technology Corp. – CSE Form 6 – Certificate of Compliance |
Certificate of compliance |
15/05/2024 |
Open Filing (102.32 KB) |
|
BIOV |
BioVaxys Technology Corp. – CSE Form 9 – Notice of Issuance or Proposed Issuance of Listed Securities |
Notice of Issuance or Proposed Issuance of Listed Securities |
15/05/2024 |
Open Filing (210.94 KB) |
